⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 3, 2024Journal of Obstetrics and Gynaecology ResearchOpen Access

Cut‐off value for anti‐Müllerian hormone in the diagnostic criteria for polycystic ovary syndrome in the Japanese population

Hiroki Noguchi Takeshi Iwasa Akira Iwase Haruhiko Kanasaki Fuminori Kimura Koji Kugu Kazuki Saito Tsuyoshi Baba Tetsuaki Hara Toshiya Matsuzaki

View Full Paper

Ask AI

Bookmark

Share

Abstract

To establish cut-off values for anti-Müllerian hormone (AMH) and antral follicle count (AFC) in the diagnostic criteria for polycystic ovary syndrome (PCOS) applicable to the Japan Society of Obstetrics and Gynecology (JSOG) 2024 criteria and the Rotterdam/International Evidence-Based Guideline for the assessment and management of PCOS (IEBG) 2023 criteria based on a nationwide survey, respectively, taking into account age, assays, and structure of the diagnostic criteria.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Noguchi et al. (2024) studied this question.

synapsesocial.com/papers/68e66601b6db6435875f2446 https://doi.org/10.1111/jog.15972

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A New Diagnostic Strategy for Polycystic Ovary Syndrome Combining Japanese and International Diagnostic Criteria Using Anti‐Müllerian HormoneClinical Guideline · 2026
2Prospective validation of anti-Müllerian hormone cutoff to determine polycystic ovarian morphology: HARMONIA studyCohort Study · 2025 · 7 citations
3The Adjunct Role of Anti Mullerian Hormone (AMH) in Diagnosing Polycystic Ovary Syndrome2024 · 1 citations
4O-193 Age-related normograms of AMH in women with polycystic ovary syndrome using three different assays2024
5Anti-Mullerian Hormone as a Surrogate Diagnostic Marker for Polycystic Ovary Syndrome2025

More related papers

The relationship of antimullerian hormone with severity of clinical symptoms in polycystic ovary syndrome2025
Anti-Mullarian Hormone As A Diagnostic Marker of Polycystic Ovary Syndrome2024
The Relationship of Antimullerian Hormone with Severity of Clinical Symptoms in Polycystic Ovary Syndrome2024

More from Journal of Obstetrics and Gynaecology Research

Women's Health Care Committee, Japan Society of Obstetrics and Gynecology: Annual Report 2025Sat,
Prenatal Diagnosis of a Rare Congenital Right Subclavian Artery–Superior Vena Cava FistulaWed,